Miruna Sasu, Ph.D, MBA — Former Head of Johnson & Johnson’s Clinical Trial Feasibility and Advanced Analytics Team — Joins COTA To Drive Clarity in Cancer Care
In her new role as Chief of Life Science Strategy, Miruna will play a critical role in setting the strategy and executing the solutions delivery to meet critical needs in partnership with life science companies to drive efficient and optimal drug development.
COTA Adds New Life Sciences Leadership to Support Growth in Demand for Oncology Real-World Data
To support growing demand for oncology real-world data, COTA is honored to announce a new addition to the team – Paige Whitney. Paige will serve as Vice President of Life Sciences at COTA.
COTA, Inc. and Kite Collaborate To Expand the Use of Real-World Data To Drive Faster, Effective Treatments for Cancers
COTA’s Real-World Data Will Complement Single-Arm Clinical Trials to Accelerate Cancer Research Benefiting Patients
Real-World Data and its Role in Addressing Cancer Health Disparities
Leveraging RWD to gain insight into cancer health disparities affecting underserved populations is key to ensuring equitable access, care, and outcomes for all patients.
Celebrating Black History Month by Supporting Equity in Clinical Trials
We work with large, de-identified data sets extracted and curated from the universe of electronic health records, claims systems, and myriad other sources. And yet, we are always brought back to the fact that amidst the data are the stories of people’s lives and their journeys of care.
COTA Expands Life Sciences Team By Bringing On Key Hire, Shariq Alavi
In our ongoing mission to bring clarity to cancer care, COTA is proud to share a new addition to our growing team — Shariq Alavi. He joins COTA as a new Vice President of Life Sciences.
World Cancer Day: Overcoming the Lack of Data in the Fight Against Pancreatic Cancer
While we have made significant advances in recent years, we are far from providing doctors and patients with the real-world data they need to consistently make treatment decisions that result in the best outcomes, and we must do better.
ASH Takeaways
The all-virtual 62nd ASH Annual Meeting & Exposition featured continued advancements in the treatment of hematologic malignancies.
Could real-world data get cancer care back on track in 2021?
In a recent article published in Forbes, COTA CEO Mike Doyle discussed the devastating impact COVID-19 has had on cancer care.
2021: The Year of Real-World Data
The pandemic has specifically accelerated the pace of innovation in the realm of real-world data, fueling a number of trends that we expect will carry on and pick up steam post-COVID.
